Wolverine Trading’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.65M | Buy |
+35,600
| New | +$9.72M | 0.01% | 950 |
|
|
2025
Q1 | – | Sell |
-19,400
| Closed | -$4.45M | – | 5650 |
|
|
2024
Q4 | $4.45M | Sell |
19,400
-13,400
| -41% | -$3.23M | ﹤0.01% | 1288 |
|
|
2024
Q3 | $7.84M | Buy |
32,800
+21,500
| +190% | +$4.8M | 0.01% | 812 |
|
|
2024
Q2 | $2.16M | Sell |
11,300
-21,800
| -66% | -$4.42M | ﹤0.01% | 1554 |
|
|
2024
Q1 | $6.55M | Sell |
33,100
-1,400
| -4% | -$257K | 0.01% | 851 |
|
|
2023
Q4 | $5.93M | Buy |
34,500
+28,500
| +475% | +$4.38M | 0.01% | 986 |
|
|
2023
Q3 | $887K | Buy |
6,000
+4,700
| +362% | +$850K | ﹤0.01% | 2208 |
|
|
2023
Q2 | $281K | Sell |
1,300
-1,000
| -43% | -$223K | ﹤0.01% | 3161 |
|
|
2023
Q1 | $497K | Buy |
+2,300
| New | +$499K | ﹤0.01% | 2505 |
|
|
2022
Q4 | – | Sell |
-2,000
| Closed | -$437K | – | 4874 |
|
|
2022
Q3 | $437K | Buy |
+2,000
| New | +$455K | ﹤0.01% | 2757 |
|
|
2022
Q2 | – | Sell |
-6,100
| Closed | -$1.52M | – | 5531 |
|
|
2022
Q1 | $1.52M | Sell |
6,100
-14,500
| -70% | -$3.51M | ﹤0.01% | 2017 |
|
|
2021
Q4 | $5.4M | Buy |
20,600
+8,700
| +73% | +$2.26M | 0.01% | 1104 |
|
|
2021
Q3 | $3.16M | Sell |
11,900
-14,500
| -55% | -$3.97M | ﹤0.01% | 1675 |
|
|
2021
Q2 | $6.5M | Buy |
26,400
+22,700
| +614% | +$4.77M | 0.01% | 942 |
|
|
2021
Q1 | $700K | Buy |
+3,700
| New | +$742K | ﹤0.01% | 3231 |
|
|
2020
Q4 | – | Sell |
-9,800
| Closed | -$1.69M | – | 5373 |
|
|
2020
Q3 | $1.69M | Sell |
9,800
-24,200
| -71% | -$4.47M | ﹤0.01% | 1603 |
|
|
2020
Q2 | $6.4M | Buy |
34,000
+4,500
| +15% | +$736K | 0.02% | 686 |
|
|
2020
Q1 | $4.55M | Buy |
29,500
+20,900
| +243% | +$3.33M | 0.01% | 818 |
|
|
2019
Q4 | $1.33M | Buy |
8,600
+1,400
| +19% | +$202K | ﹤0.01% | 2164 |
|
|
2019
Q3 | $962K | Sell |
7,200
-7,900
| -52% | -$1.04M | ﹤0.01% | 2027 |
|
|
2019
Q2 | $1.84M | Sell |
15,100
-34,000
| -69% | -$3.77M | 0.01% | 1570 |
|
|
2019
Q1 | $5.11M | Buy |
+49,100
| New | +$5.07M | 0.01% | 867 |
|
|
2018
Q4 | – | Sell |
-23,000
| Closed | -$2.65M | – | 5194 |
|
|
2018
Q3 | $2.65M | Buy |
23,000
+19,300
| +522% | +$2.11M | 0.01% | 1429 |
|
|
2018
Q2 | $364K | Hold |
3,700
| – | – | ﹤0.01% | 3510 |
|
|
2018
Q1 | $364K | Buy |
+3,700
| New | +$350K | ﹤0.01% | 3510 |
|
|
2017
Q3 | – | Sell |
-4,000
| Closed | -$308K | – | 4911 |
|
|
2017
Q2 | $308K | Buy |
+4,000
| New | +$286K | ﹤0.01% | 3002 |
|
|
2017
Q1 | – | Sell |
-6,200
| Closed | -$385K | – | 4882 |
|
|
2016
Q4 | $385K | Sell |
6,200
-5,700
| -48% | -$349K | ﹤0.01% | 2945 |
|
|
2016
Q3 | $764K | Buy |
+11,900
| New | +$792K | ﹤0.01% | 2156 |
|
Other funds holding RMD
Wolverine Trading's RMD Position: Q4 2024 in Review
Wolverine Trading sold out of ResMed (RMD) in Q4 2024, closing a stake of 2,350 shares — an estimated $566K sold.
Wolverine Trading first reported a position in RMD in Q2 2017 and held it in 18 quarters. The position peaked at $2.74M in Q2 2021. 871 funds tracked by Wall St. Rank hold RMD as of Q4 2024.
- Wolverine Trading reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
- Wolverine Trading sold 2,350 ResMed shares in Q4 2024, an estimated $566K.
- Wolverine Trading first reported a position in ResMed in Q2 2017 and held it in 18 quarters.
- Wolverine Trading's ResMed position peaked at $2.74M in Q2 2021.
- 871 funds tracked by Wall St. Rank held ResMed as of Q4 2024.
Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.